Life Sciences and Healthcare

Physician digital infographic – 3 must dos for physician engagement

DRG Digital – Manhattan Research's Taking the Pulse® U.S. 2017 study asked 2,784 U.S. physicians across 25+ specialties about their use of emerging technology, how they find information and make decisions, and what they want from pharma companies. The aim of the study is to help marketers refocus their digital efforts on what works and plan more effective multichannel campaigns.

Lead analyst Kelly Pinola comments,  "Pharma needs to dial down the promotional messaging and lead with valuable educational resources in order to regain physician trust. The good news for pharmas is that there’s an opportunity here for them to differentiate themselves as truly user-centered organizations, since this is a problem we’re seeing across the industry.”

Three key findings for marketers are highlighted in the infographic – contact us to learn more about accessing the full study results or a Physician Multichannel Playbook for your specific physician audience.

Click to enlarge infographic

 

Hospital gift shops: Q&a with an industry expert

Many distinguishing factors set apart hospital gift shops from other retailers. They operate with largely volunteer staffs in sensitive environments, merchandising to a captive customer base. If managed properly, these stores can both contribute to a hospital’s healing culture and be significant sources of revenue for their organizations. To learn more, The Academy recently spoke […]

Partnering priorities: Do your homework, tell your story

Companies use meetings like BIO CEO and BIO International as sounding boards for fine-tuning company strategy, weighing, for example, the wisdom of taking an asset all the way through to commercialization or teaming up with a strategic partner.

Digital health news update: new focus on digital at FDA and Merck

FDA is establishing a digital health unit under the Center for Devices and Radiological Health which will weigh the agency’s approach on topics like AI, advanced analytics, telemedicine and interoperability. Meanwhile, the agency is working through the use of real world evidence and “what clinical validation for software looks like.” Merck has “significantly decreased spend on […]

Don’t Expect House Health Reform to Move Far in Senate

When does a Congressional bill move forward but not possess much in the way of forward momentum? That will grow apparent as the American Health Care Act moves to the Senate. With a 217-213 vote, the U.S. House on May 4 passed the American Health Care Act (AHCA), the Republican replacement for the Affordable Care […]

Teva Nabs First True Generic Salmeterol/Fluticasone Propionate Launch in the United States, While GlaxoSmithKline Keeps its Cool

Teva recently launched the first true generic salmeterol/fluticasone propionate for asthma in the United States, but in a surprise twist, the generic is an authorized generic to Teva’s own “branded-generic” salmeterol/fluticasone propionate, AirDuo RespiClick, and is not directly substitutable with GlaxoSmithKline’s Advair. It was a clever move on Teva’s part to get approval for a […]

Digital health news update: Verily’s big data bonanza Baseline

Verily’s Study Watch Verily announced plans for a massive new study, dubbed Project Baseline, which aims to uncover disease risk factors by tracking the health of 10,000 individuals over four years using a purpose-built watch and other sensors, an online portal and periodic in-person workups. The project partners Verily with the medical schools of Duke and Stanford, which […]

Innovation comes with hefty price tag as biopharma R&D spend climbs

To keep biopharmaceutical innovation churning requires mountains of cash. Companies will need to invest as much as $2.5 billion over a 10- to 15-year period in order to bring a new therapy to the marketplace, according to a 2014 study conducted by the Tufts Center for the Study of Drug Development.